Paratek (formerly Transcept Pharmaceuticals)
Boston, United States · Founded 1996 · $140.0M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 201–500
- Founded
- 1996
- Business Model
- B2B
- Website
- paratekpharma.com
- Total Funding
- $140.0M
- Last Round
- $140.0M Convertible NoteApr 2018
- Rounds
- 1
About
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychiatry and sleep medicine
Summary
Paratek (formerly Transcept Pharmaceuticals) is a Biotech company based in Boston, United States, founded in 1996. It has raised $140.0M in total across 1 round, most recently a $140.0M Convertible Note round in Apr 2018. Investors include Gurnet Point Capital, Novo Holdings A/S and Aisling Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2023
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...